Wegovy vs Zepbound: how to compare the two weight-loss medications

Start with the active ingredient

Wegovy is a semaglutide product and Zepbound is a tirzepatide product. That distinction matters because active ingredients can have different dosing, warnings, insurance rules, clinical evidence, and availability.

Compare the approved use being discussed

Both products are associated with chronic weight management, but indications can change over time and can differ by product, dose, and patient situation. Ask your clinician which FDA-approved indication is relevant to your case.

• What condition or indication is being discussed?
• Is the medication being used according to its approved labeling?
• Are there alternative treatments that fit my health history better?

Look beyond average weight-loss headlines

Marketing comparisons and trial averages cannot decide which medication is appropriate for you. Your clinician should consider medical history, contraindications, side effects, other medications, goals, and insurance access.

Ask about warnings and monitoring

Both products have labeling that includes warnings and common side effects. Ask what symptoms should prompt a call, what labs or monitoring are needed, and what happens before surgery or other procedures.

Cost may decide the real-world path

The best clinical option on paper may still be hard to access if coverage is denied or supply is limited. Ask for a plan A, plan B, and cash-pay fallback before choosing a provider.